FINWIRES · TerminalLIVE
FINWIRES

Buckle's Margin Pressures Likely to Persist, UBS Says

By

Buckle's (BKE) fiscal Q2 showed ongoing margin pressure and higher costs, making the stock less attractive compared with other opportunities, UBS Securities said in a note Monday.

While merchandise margins remain resilient, higher store-related costs and additional investments are likely to weigh on earnings growth in the coming quarters, the investment firm said.

Buckle is expected to deliver mid-single-digit long-term earnings per share growth and a high-single-digit dividend yield, the analysts said, adding that this return profile is not strong enough to drive a meaningful increase in the stock's valuation or lead to outperformance. "Additionally, we see more attractive opportunities across our coverage universe."

The analysts raised their fiscal 2026 EPS estimate by 5 cents to reflect the benefit from tariff refunds. They also slightly increased their fiscal 2026-2027 sales growth forecasts, driven by stronger performance from new stores and relocated stores. They added that their fiscal 2027-2028 EPS estimates remain unchanged.

UBS maintained its neutral rating and $46 price target on Buckle.

Shares of Buckle were up more than 1% in Monday trading.

Price: $44.35, Change: $+0.53, Percent Change: +1.22%

Related Articles

Wire

Update: Regal Partners H1 Normalized Earnings, Revenue Up; Shares Fall 7%

(Updates to add stock movement in the headline and the last paragraph)Regal Partners (ASX:RPL) logged AU$0.214 in normalized EPS for the first half, compared with AU$0.105 a year ago, a Monday filing showed.For the six months ended June 30, income from ordinary activities was AU$226.4 million versus AU$128.7 million previously, the Australia-listed alternative investment manager company added.The board declared an interim dividend of AU$0.12 per share, up from AU$0.06 a year earlier, payable Sept. 30 to shareholders on record as of Aug. 31.The company's shares fell around 7% in recent Monday trade.

ASX:RPL
Wire

Philip Morris Reports FDA Authorization for ZYN ULTRA Nicotine Pouches

Philip Morris International (PM) said Friday it has obtained authorization from the US Food and Drug Administration for the marketing of 11 ZYN ULTRA moist oral nicotine pouch products.The firm said the FDA issued Marketing Granted Orders to its US affiliate, Swedish Match USA. Additional 11mg variants are still under scientific review, it added.The authorizations add selection of ZYN ULTRA products to its portfolio of alternatives for adults who smoke or use traditional oral tobacco products, the company said.Price: $188.44, Change: $-3.08, Percent Change: -1.61%

$PM
Wire

Top Cryptocurrencies Jump; Bitcoin Tops $77,000

Major digital assets jumped Friday, with Bitcoin (BTC-USD) topping $77,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 6.4% in the past 24 hours. The Nasdaq 100 and the S&P 500 each gained 0.5%, and the Dow Jones Industrial Average increased 0.8.%.Bitcoin gained 6.1% to $77,122, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose 16% to $71.1 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 3.6% to $2,414.XRP (XRP-USD) surged 11%, BNB (BNB-USD) increased 3.7%, and Solana (SOL-USD) added 4%. Dogecoin (DOGE-USD) rose 5.7%, while Cardano (ADA-USD) jumped 11%.The total market value of the cryptocurrency industry rose 5.1% in the past 24 hours to $2.59 trillion, with trading volume gaining 9.2% to $161.4 billion.Price: $77126.61, Change: $+4113.61, Percent Change: +5.63%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD